Fluxion Biosciences Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Fluxion Biosciences Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10325
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fluxion Biosciences Inc (Fluxion) is a provider of analytical instruments for functional cellular analyses. The company’s liquid biopsy technologies include IsoFlux CTC liquid biopsy system, ERASE-Seq variant caller for liquid biopsies and the Spotlight 59 for ultra-sensitive NGS mutation detection for CTC and ctDNA samples. It also provides analytical services for a range of liquid biopsy and CTC applications, including cell-free DNA and CTC sequencing, gene expression, CTC enumeration and protein marker detection, among others. The company serves leading cancer centers developing tests for patient monitoring and early cancer detection; leading academic institutions; and government research organizations. It markets products through a network of distributors in the US, Australia, Spain, and Singapore, among others. Fluxion is headquartered in Alameda, California, the US.

Fluxion Biosciences Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fluxion Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Fluxion Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Fluxion Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Fluxion Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Fluxion Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Fluxion Biosciences Inc, Medical Equipment, Deal Details 10
Partnerships 10
Fluxion Biosciences Enters into Distribution Agreement with Harvard Bioscience 10
Fluxion Bioscience Forms Partnership with University of Texas Health Science Center 11
Fluxion Biosciences Enters into Co-Development Agreement with Stanford University School of Medicine 12
Fluxion Biosciences Enters Into Co-Development Agreement With Stanford University School of Medicine 13
Fluxion Bioscience Enters Into Technology Integration Agreement With Rubicon Genomics 14
Fluxion Biosciences Inc – Key Competitors 15
Fluxion Biosciences Inc – Key Employees 16
Fluxion Biosciences Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Product News 18
Jun 01, 2018: New Data Demonstrates Superior Accuracy of Fluxion’s ERASE-Seq Variant Caller for Liquid Biopsies 18
Dec 14, 2017: Fluxion Biosciences Launches New BioFlux Plate for Studying Catheter Infections 19
Other Significant Developments 20
Jan 04, 2018: Fluxion Biosciences Announces Launch of ERASE-Seq NGS Liquid Biopsy Analysis Service 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Fluxion Biosciences Inc, Medical Equipment, Key Facts 2
Fluxion Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Fluxion Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Fluxion Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Fluxion Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Fluxion Biosciences Inc, Deals By Market, 2012 to YTD 2018 8
Fluxion Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Fluxion Biosciences Enters into Distribution Agreement with Harvard Bioscience 10
Fluxion Bioscience Forms Partnership with University of Texas Health Science Center 11
Fluxion Biosciences Enters into Co-Development Agreement with Stanford University School of Medicine 12
Fluxion Biosciences Enters Into Co-Development Agreement With Stanford University School of Medicine 13
Fluxion Bioscience Enters Into Technology Integration Agreement With Rubicon Genomics 14
Fluxion Biosciences Inc, Key Competitors 15
Fluxion Biosciences Inc, Key Employees 16

List of Figures
Fluxion Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Fluxion Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Fluxion Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Fluxion Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Fluxion Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Fluxion Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Fluxion Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Fluxion Biosciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Fluxion Biosciences Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • VQ OrthoCare:企業の戦略的SWOT分析
    VQ OrthoCare - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • De Beers Group Plc:企業の戦略・SWOT・財務情報
    De Beers Group Plc - Strategy, SWOT and Corporate Finance Report Summary De Beers Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • NovaMedica LLC-製薬・医療分野:企業M&A・提携分析
    Summary NovaMedica LLC is a drug company that offers gastroenterology and ophthalmology products. The company offers pharmaceutical and other medical products such as diagnostic equipment, medical devices and technologies designed to provide a solution for range of interrelated problems. It provides …
  • Koki Holdings Co Ltd:企業の戦略的SWOT分析
    Koki Holdings Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Net Medical Xpress Solutions Inc (NMXS):企業の財務・戦略的SWOT分析
    Summary Net Medical Xpress Solutions Inc (NMX) is a provider of collaborative tools for quality and secured digital consultations. The company offers web-based clinical telemedicine solution that allows to cut down on unnecessary transport by allowing the realtime assessment of patients through a vi …
  • Coca-Cola Icecek A.S.:戦略・SWOT・企業財務分析
    Coca-Cola Icecek A.S. - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola Icecek A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • StormGeo AS:石油・ガス:M&Aディール及び事業提携情報
    Summary StormGeo AS (StormGeo) is a weather forecast company that offers professional weather services and decision support for weather sensitive operations. The company operates through segments that include shipping, oil and gas, marine operations, renewable, aviation, cross industry and media. It …
  • PCI Biotech Holding ASA (PCIB):企業の財務・戦略的SWOT分析
    Summary PCI Biotech Holding ASA (PCI Biotech) is a biopharmaceutical company that focus on development and commercialisation of novel therapies for the treatment of cancer. The company develops therapeutic products based on its proprietary photochemical internalisation technology. Its lead product c …
  • Plastopil Hazorea Company Ltd:企業の戦略・SWOT・財務情報
    Plastopil Hazorea Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Plastopil Hazorea Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • The Interpublic Group of Companies, Inc.:企業の戦略・SWOT・財務分析
    The Interpublic Group of Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Interpublic Group of Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Santos Limited:企業の戦略・SWOT・財務分析
    Santos Limited - Strategy, SWOT and Corporate Finance Report Summary Santos Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Paysafe Group Plc:企業の戦略的SWOT分析
    Paysafe Group Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Carna Biosciences Inc (4572):企業の財務・戦略的SWOT分析
    Summary Carna Biosciences Inc (Carna) is a biotechnology company that discovers and develops drugs for the treatment of cancer and inflammatory diseases. The company offers products such as kinase proteins, biotinylated kinases, substrates, assay kits, protein substrates, inactive kinases, inactive- …
  • Jiangsu Jiuding New Material Co Ltd (002201):企業の財務・戦略的SWOT分析
    Jiangsu Jiuding New Material Co Ltd (002201) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Cancer Research Technology Ltd.:企業のM&A・事業提携・投資動向
    Cancer Research Technology Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cancer Research Technology Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Latecoere S.A.:企業の戦略・SWOT・財務情報
    Latecoere S.A. - Strategy, SWOT and Corporate Finance Report Summary Latecoere S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Northern Trust Corporation:企業のM&A・事業提携・投資動向
    Northern Trust Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Northern Trust Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Statnett SF-エネルギー分野:企業M&A・提携分析
    Summary Statnett SF (Statnett) transmits and distributes high voltage electricity in Norway primarily generated from its hydro-electric power plants. It operates as a system operator in the Norwegian energy system. The company is a state enterprise, established under the Act relating to state-owned …
  • Centrus Energy Corp.:企業の戦略・SWOT・財務分析
    Centrus Energy Corp. - Strategy, SWOT and Corporate Finance Report Summary Centrus Energy Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Proteomics International Laboratories Ltd (PIQ):製品パイプライン分析
    Summary Proteomics International Laboratories Ltd (Proteomics International), a wholly-owned subsidiary and trading name of PILL, is a medical technology company, which focuses on proteomics, the study of structure and function of proteins. The company harnesses its proprietary proteomics-based tech …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆